BlackRock Fund Advisors recently announced the acquisition of new stake in OPKO Health Inc. (NASDAQ:OPK). The institutional investor has increased its shareholding in the Healthcare company by 4.49% to 32.73 million shares with purchase of 1.41 million shares. This fresh investment now brings its stake to 4.89% valued currently at $168.56 million. In addition, SSgA Funds Management, Inc. raised its holdings by 12.02 million to 30.46 million shares. And Oracle Investment Management, Inc.. has lifted its position by 169.30% or 7.57 million shares – to 12.05 million shares.
With over 6.66 million OPKO Health Inc. (OPK) shares trading Friday and a closing price of $4.86 on the day, the dollar volume was approximately $32.38 million. The shares have shown a positive weekly performance of 1.25% and its price on 08/21/20 lost nearly -1.42%. Currently, there are 640.58M common shares owned by the public and among those 403.12M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 5 analysts who have offered their price forecasts for OPK have a consensus price objective of $8.00. The analysts have set the share’s price value over the next 12 months at a high of $10.00 and a low of $6.50 should the stock experience a downside. Incidentally, analysts’ outlook for the OPKO Health Inc. stock is 1.80 for the next 12 months. The average price target is 39.25% above its last price level and an upside to the estimated low will see the stock gain 25.23% over that period. But an upside of 51.4% will see the stock hit the forecast high price target while mean target price for the stock is $7.75.
Insiders at the company have transacted a total of 251 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 251 of these insider trades were purchases, accounting for 10,193,304 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in OPKO Health Inc. are SPDR S&P Biotech ETF, Vanguard Total Stock Market Index, and Vanguard Small Cap Index Fund. SPDR S&P Biotech ETF owns 23.42 million shares of the company’s stock, all valued at over $120.61 million. The company sold -0.23 million shares recently to bring their total holdings to about 3.50% of the shares outstanding. Vanguard Total Stock Market Index bought 732.0 shares to see its total holdings expand to 11.39 million shares valued at over $58.65 million and representing 1.70% of the shares outstanding. Vanguard Small Cap Index Fund sold 98463.0 shares to bring its total holdings to over 9.98 million shares at a value of $51.38 million. Vanguard Small Cap Index Fund now owns shares totaling to 1.49% of the shares outstanding.
Shares of OPKO Health Inc. (NASDAQ: OPK) opened at $4.91, down -$0.02 from a prior closing price of $4.93. However, the script later closed the day at $4.86, down -1.42%. The company’s stock has a 5-day price change of 1.25% and 89.84% over the past three months. OPK shares are trading 230.61% year to date (YTD), with the 12-month market performance up to 149.23% higher. It has a 12-month low price of $1.12 and touched a high of $6.47 over the same period. Currently, 6.66 million shares have been traded, compared to an average intraday trading volume of 17.16 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -8.37%, 14.25%, and 105.21% respectively.
Institutional ownership of OPKO Health Inc. (NASDAQ: OPK) shares accounts for 30.70% of the company’s 640.58M shares outstanding. Mutual fund holders own 45.12%, while other institutional holders and individual stakeholders account for 9.51% and 21.26% respectively.
It has a market capitalization of $3.30B and a beta (3y monthly) value of 2.33. The earnings-per-share (ttm) stands at -$0.33. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.42% over the week and 7.33% over the month.
Analysts forecast that OPKO Health Inc. (OPK) will achieve an EPS of $0.04 for the current quarter, $0.05 for the next quarter and $0.21 for 2021. The lowest estimate earnings-per-share for the quarter is $0.04 while analysts give the company a high EPS estimate of $0.06. Comparatively, EPS for the current quarter was -$0.11 a year ago. Earnings per share for the fiscal year are expected to decrease by -94.60%, and 365.22% over the next financial year. EPS should grow at an annualized rate of 12.00% over the next five years, compared to -5.40% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 5 brokerage firm advisors rate OPKO Health Inc. (OPK) as a “Strong Buy” at a consensus score of 1.80. Specifically, 4 Wall Street analysts polled rate the stock as a buy, while 1 of the 5 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the OPK, a number of firms have released research notes about the stock. Piper Jaffray stated their Overweight rating for the stock in a research note on November 25, 2019, with the firm’s price target at $2.50. JP Morgan coverage for the OPKO Health Inc. (OPK) stock in a research note released on March 02, 2018 offered a Underweight rating with a price target of. JP Morgan was of a view on September 14, 2017 that the stock is Neutral, while Standpoint Research gave the stock Buy rating on June 21, 2016, issuing a price target of $16- $18. Standpoint Research on their part issued Buy rating on June 03, 2016.